Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Current Assets (2022 - 2025)

Praxis Precision Medicines has reported Current Assets over the past 4 years, most recently at $610.9 million for Q4 2025.

  • Quarterly results put Current Assets at $610.9 million for Q4 2025, up 51.08% from a year ago — trailing twelve months through Dec 2025 was $610.9 million (up 51.08% YoY), and the annual figure for FY2025 was $610.9 million, up 51.08%.
  • Current Assets for Q4 2025 was $610.9 million at Praxis Precision Medicines, up from $273.8 million in the prior quarter.
  • Over the last five years, Current Assets for PRAX hit a ceiling of $610.9 million in Q4 2025 and a floor of $84.9 million in Q4 2023.
  • Median Current Assets over the past 4 years was $223.1 million (2022), compared with a mean of $245.2 million.
  • Biggest five-year swings in Current Assets: crashed 59.74% in 2023 and later surged 376.4% in 2024.
  • Praxis Precision Medicines' Current Assets stood at $110.8 million in 2022, then fell by 23.42% to $84.9 million in 2023, then surged by 376.4% to $404.4 million in 2024, then soared by 51.08% to $610.9 million in 2025.
  • The last three reported values for Current Assets were $610.9 million (Q4 2025), $273.8 million (Q3 2025), and $306.6 million (Q2 2025) per Business Quant data.